US FDA contemplates collection of pharmacogenomic data.
Kling
Jim
J
D026683:Advisory Committees; D003625:Data Collection / Q000331:legislation & jurisprudence / Q000379:methods; D010597:Pharmacogenetics / Q000331:legislation & jurisprudence* / Q000379:methods*; D011358:Product Surveillance, Postmarketing / Q000379:methods* / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration